These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24899134)

  • 1. Aneuploidy in pluripotent stem cells and implications for cancerous transformation.
    Na J; Baker D; Zhang J; Andrews PW; Barbaric I
    Protein Cell; 2014; 5(8):569-79. PubMed ID: 24899134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
    Krivec N; Ghosh MS; Spits C
    Stem Cell Reports; 2024 Jan; 19(1):11-27. PubMed ID: 38157850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
    Peterson SE; Garitaonandia I; Loring JF
    Bioessays; 2016 Jul; 38 Suppl 1():S86-95. PubMed ID: 27417126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic instability in human pluripotent stem cells.
    Nguyen HT; Geens M; Spits C
    Hum Reprod Update; 2013; 19(2):187-205. PubMed ID: 23223511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Competition Eliminates Aneuploid Human Pluripotent Stem Cells.
    Ya A; Deng C; Godek KM
    bioRxiv; 2024 May; ():. PubMed ID: 38766106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.
    Ben-David U; Arad G; Weissbein U; Mandefro B; Maimon A; Golan-Lev T; Narwani K; Clark AT; Andrews PW; Benvenisty N; Carlos Biancotti J
    Nat Commun; 2014 Sep; 5():4825. PubMed ID: 25198699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
    Keller A; Spits C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the Genetic Stability of Human Naïve and Primed Pluripotent Stem Cells.
    Baker D; Barbaric I
    Methods Mol Biol; 2022; 2416():267-284. PubMed ID: 34870842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic stem cells as models for aneuploid chromosomal syndromes.
    Biancotti JC; Narwani K; Buehler N; Mandefro B; Golan-Lev T; Yanuka O; Clark A; Hill D; Benvenisty N; Lavon N
    Stem Cells; 2010 Sep; 28(9):1530-40. PubMed ID: 20641042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
    Price CJ; Barbaric I
    Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects.
    Lamm N; Ben-David U; Golan-Lev T; Storchová Z; Benvenisty N; Kerem B
    Cell Stem Cell; 2016 Feb; 18(2):253-61. PubMed ID: 26669899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival.
    Zhang J; Hirst AJ; Duan F; Qiu H; Huang R; Ji Y; Bai L; Zhang F; Robinson D; Jones M; Li L; Wang P; Jiang P; Andrews PW; Barbaric I; Na J
    Stem Cell Reports; 2019 Mar; 12(3):557-571. PubMed ID: 30773485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy.
    Peterson SE; Westra JW; Rehen SK; Young H; Bushman DM; Paczkowski CM; Yung YC; Lynch CL; Tran HT; Nickey KS; Wang YC; Laurent LC; Loring JF; Carpenter MK; Chun J
    PLoS One; 2011; 6(8):e23018. PubMed ID: 21857983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How aneuploidy affects metabolic control and causes cancer.
    Rasnick D; Duesberg PH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):621-30. PubMed ID: 10359645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.
    Al Delbany D; Ghosh MS; Krivec N; Huyghebaert A; Regin M; Duong MC; Lei Y; Sermon K; Olsen C; Spits C
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genomic Health of Human Pluripotent Stem Cells: Genomic Instability and the Consequences on Nuclear Organization.
    Henry MP; Hawkins JR; Boyle J; Bridger JM
    Front Genet; 2018; 9():623. PubMed ID: 30719030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.
    Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH
    Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered peptide modified hydrogel platform for propagation of human pluripotent stem cells.
    Richardson T; Wiegand C; Adisa F; Ravikumar K; Candiello J; Kumta P; Banerjee I
    Acta Biomater; 2020 Sep; 113():228-239. PubMed ID: 32603868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.